izvor podataka: crosbi
!
Ustekinumab in patients with moderate and severe psoriasis: our experience (CROSBI ID 618672)
Prilog sa skupa u zborniku | sažetak izlaganja sa skupa | međunarodna recenzija
Bakija-Konsuo, Ana ; Čarija Antoanela
Ustekinumab in patients with moderate and severe psoriasis: our experience // Abstract on CD. 2014
Podaci o odgovornosti
Bakija-Konsuo, Ana ; Čarija Antoanela
engleski
Ustekinumab in patients with moderate and severe psoriasis: our experience
The aim of this report is to present our experience of ustekinumab in Croatian patients with long-standing, moderate-to-severe plaque psoriasis. We present 9 patients who received ustekinumab 45 or 90 mg at weeks 0 and 4. They have continued treatment every 12 weeks.
psoriasis; ustekinumab; side effects
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o prilogu
2014.
objavljeno
Podaci o matičnoj publikaciji
Abstract on CD
Podaci o skupu
EADV congress
poster
08.10.2014-12.10.2014
Amsterdam, Nizozemska
Povezanost rada
Povezane osobe
Povezane ustanove